Clinical characteristics of 3062 COVID‐19 patients: A meta‐analysis
Top Cited Papers
- 24 June 2020
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 92 (10), 1902-1914
- https://doi.org/10.1002/jmv.25884
Abstract
Coronavirus disease 2019 (COVID‐19) has spread rapidly around the world since its emergence in humans last December. Previous studies suggested that numerous markers of inflammation were elevated in patients in with severe disease relative to patients with milder conditions, and an elevated level of interleukin‐6 (IL‐6) was associated with a high case fatality of COVID‐19 infection.Keywords
Funding Information
- National Natural Science Foundation of China (81960343; the Emergency Science and Technology Brainstorm Project for the Prevention and Control of COVID‐19, which is part of the Guangxi Key Research and Development Plan, Grant/Award Number: AB20058002; and the High‐level Medical Expert Training Program of Guangxi“139”Plan Funding, Grant/Award Number: G201903027)
This publication has 32 references indexed in Scilit:
- Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, ChinaJAMA, 2020
- A Novel Coronavirus Emerging in China — Key Questions for Impact AssessmentThe New England Journal of Medicine, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmissionScience China Life Sciences, 2020
- Wave-CAIPI susceptibility-weighted imaging achieves diagnostic performance comparable to conventional susceptibility-weighted imaging in half the scan timeEuropean Radiology, 2020
- Chronic hepatitis B: dynamic change in Traditional Chinese Medicine syndrome by dynamic network biomarkersChinese Medicine, 2019
- Severe Acute Respiratory SyndromeInfectious Disease Clinics of North America, 2019
- The Middle East Respiratory Syndrome (MERS)Infectious Disease Clinics of North America, 2019